TY - JOUR
T1 - Growth factor responsiveness
T2 - Role of MyoD and myogenin
AU - Wolf, Joseph R.
AU - Hirschhorn, Ricky R.
AU - Steiner, Sheldon M.
N1 - Funding Information:
We thank Drs. Marion Steiner and Lester Goldstein for their critical reading of the manuscript and Dr. Mike Clark for his heipful discussions. We thank Dr. Weintraub for providmg antibody against MyoD and Drs. Lassar and Wright for providmg MyoD and myogenin expression vectors, respectively. This work was supported (in part) by a Grant-in Aid from the American Heart Association, Kentucky Affih-ate (S.M.S.) and Grant CA 43798 from NIH (R.R.H.).
PY - 1992/9
Y1 - 1992/9
N2 - A differentiation-defective variant (DD-1) of the MM14 myoblasts acquired the ability to synthesize DNA in response to treatment with epidermal growth factor (EGF) (R. W. Lim and S. D. Hauschka, 1984, Dev. Biol. 105, 48) and no longer expressed myogenic determinant genes (i.e., MyoD and myogenin) (P. R. Mueller, and B. Wold, 1989, Science 246, 780). To determine the effect of expression of MyoD on EGF responsiveness, DD-1 cells were cotransfected with a MyoD expression vector and with pRSVneo. A clone, MyoDD-1 cells, which was G418 resistant, formed multinuclear syncitia, and also expressed MyoD and myogenin, was further characterized. EGF responsiveness, as assessed by DNA synthesis, was decreased 5- to 10-fold in the MyoDD-1 cells from that in G418-resistant control DD-1 cells, despite similar EGF receptor numbers and binding affinities of the receptors. Responsiveness of MyoDD-1 cells to fibroblast growth factor (FGF) was also diminished although to a lesser extent. To determine the effects of decreased myogenic determinant gene expression on mitogen responsiveness, MM14 myoblasts were grown in medium supplemented with 5 μM 5-bromo-2′-deoxyuridine (BUdR-MM14). BUdR-MM14 cells had decreased expression of MyoD and myogenin, did not fuse, and had an altered morphology, from round to flat. The BUdR effect on fusion and cell shape was reversed by growth in control medium. BUdR-MM14 cells were responsive to EGF and had enhanced responsiveness to FGF. The combined studies support the view that expression of MyoD and/or myogenin contributes to negative regulation of mitogen responsiveness.
AB - A differentiation-defective variant (DD-1) of the MM14 myoblasts acquired the ability to synthesize DNA in response to treatment with epidermal growth factor (EGF) (R. W. Lim and S. D. Hauschka, 1984, Dev. Biol. 105, 48) and no longer expressed myogenic determinant genes (i.e., MyoD and myogenin) (P. R. Mueller, and B. Wold, 1989, Science 246, 780). To determine the effect of expression of MyoD on EGF responsiveness, DD-1 cells were cotransfected with a MyoD expression vector and with pRSVneo. A clone, MyoDD-1 cells, which was G418 resistant, formed multinuclear syncitia, and also expressed MyoD and myogenin, was further characterized. EGF responsiveness, as assessed by DNA synthesis, was decreased 5- to 10-fold in the MyoDD-1 cells from that in G418-resistant control DD-1 cells, despite similar EGF receptor numbers and binding affinities of the receptors. Responsiveness of MyoDD-1 cells to fibroblast growth factor (FGF) was also diminished although to a lesser extent. To determine the effects of decreased myogenic determinant gene expression on mitogen responsiveness, MM14 myoblasts were grown in medium supplemented with 5 μM 5-bromo-2′-deoxyuridine (BUdR-MM14). BUdR-MM14 cells had decreased expression of MyoD and myogenin, did not fuse, and had an altered morphology, from round to flat. The BUdR effect on fusion and cell shape was reversed by growth in control medium. BUdR-MM14 cells were responsive to EGF and had enhanced responsiveness to FGF. The combined studies support the view that expression of MyoD and/or myogenin contributes to negative regulation of mitogen responsiveness.
UR - http://www.scopus.com/inward/record.url?scp=0026644422&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026644422&partnerID=8YFLogxK
U2 - 10.1016/0014-4827(92)90409-2
DO - 10.1016/0014-4827(92)90409-2
M3 - Article
C2 - 1324843
AN - SCOPUS:0026644422
SN - 0014-4827
VL - 202
SP - 105
EP - 112
JO - Experimental cell research
JF - Experimental cell research
IS - 1
ER -